Charles Schwab Investment Management Inc Haemonetics Corp Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 542,716 shares of HAE stock, worth $41.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
542,716
Previous 546,783 0.74%
Holding current value
$41.6 Million
Previous $45.2 Million 3.57%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$72.45 - $91.58 $294,654 - $372,455
-4,067 Reduced 0.74%
542,716 $43.6 Million
Q2 2024

Aug 12, 2024
SELL
$81.24 - $97.37 $162 - $194
-2 Reduced -0.0%
546,783 $45.2 Million
Q1 2024

May 08, 2024
BUY
$71.24 - $85.35 $861,362 - $1.03 Million
12,091 Added 2.26%
546,785 $46.7 Million
Q4 2023

Feb 06, 2024
BUY
$80.59 - $92.61 $717,331 - $824,321
8,901 Added 1.69%
534,694 $45.7 Million
Q3 2023

Nov 08, 2023
BUY
$82.56 - $93.49 $2.75 Million - $3.11 Million
33,294 Added 6.76%
525,793 $47.1 Million
Q2 2023

Aug 09, 2023
BUY
$80.84 - $89.45 $501,369 - $554,768
6,202 Added 1.28%
492,499 $41.9 Million
Q1 2023

May 11, 2023
SELL
$72.75 - $90.6 $659,333 - $821,107
-9,063 Reduced 1.83%
486,297 $40.2 Million
Q4 2022

Feb 13, 2023
SELL
$73.85 - $86.14 $803,118 - $936,772
-10,875 Reduced 2.15%
495,360 $39 Million
Q3 2022

Nov 14, 2022
BUY
$63.3 - $78.66 $324,285 - $402,975
5,123 Added 1.02%
506,235 $37.5 Million
Q2 2022

Aug 15, 2022
BUY
$49.27 - $66.08 $66,465 - $89,141
1,349 Added 0.27%
501,112 $32.7 Million
Q1 2022

May 13, 2022
BUY
$43.77 - $63.22 $1.54 Million - $2.22 Million
35,078 Added 7.55%
499,763 $31.6 Million
Q4 2021

Feb 11, 2022
BUY
$49.55 - $74.59 $1.61 Million - $2.42 Million
32,469 Added 7.51%
464,685 $24.6 Million
Q3 2021

Nov 16, 2021
BUY
$57.6 - $70.59 $625,593 - $766,677
10,861 Added 2.58%
432,216 $30.5 Million
Q2 2021

Aug 16, 2021
BUY
$51.81 - $118.56 $6.65 Million - $15.2 Million
128,346 Added 43.8%
421,355 $28.1 Million
Q1 2021

May 17, 2021
BUY
$111.01 - $139.48 $139,650 - $175,465
1,258 Added 0.43%
293,009 $32.5 Million
Q4 2020

Feb 16, 2021
SELL
$88.75 - $119.95 $718,963 - $971,714
-8,101 Reduced 2.7%
291,751 $34.6 Million
Q3 2020

Nov 13, 2020
SELL
$75.65 - $93.58 $1.69 Million - $2.09 Million
-22,364 Reduced 6.94%
299,852 $26.2 Million
Q2 2020

Aug 14, 2020
SELL
$84.96 - $118.91 $8.47 Million - $11.9 Million
-99,693 Reduced 23.63%
322,216 $28.9 Million
Q1 2020

May 15, 2020
BUY
$74.34 - $121.82 $1.93 Million - $3.16 Million
25,912 Added 6.54%
421,909 $42 Million
Q4 2019

Feb 07, 2020
BUY
$114.37 - $129.46 $1.35 Million - $1.52 Million
11,767 Added 3.06%
395,997 $45.5 Million
Q3 2019

Nov 08, 2019
SELL
$117.16 - $138.52 $9.27 Million - $11 Million
-79,137 Reduced 17.08%
384,230 $48.5 Million
Q2 2019

Aug 09, 2019
SELL
$81.74 - $120.34 $1.9 Million - $2.79 Million
-23,201 Reduced 4.77%
463,367 $55.8 Million
Q1 2019

May 14, 2019
BUY
$83.25 - $102.12 $1.23 Million - $1.51 Million
14,753 Added 3.13%
486,568 $42.6 Million
Q4 2018

Feb 14, 2019
SELL
$90.66 - $116.63 $5.66 Million - $7.28 Million
-62,390 Reduced 11.68%
471,815 $47.2 Million
Q3 2018

Nov 13, 2018
BUY
$89.96 - $114.58 $144,475 - $184,015
1,606 Added 0.3%
534,205 $61.2 Million
Q2 2018

Aug 08, 2018
BUY
$71.53 - $95.75 $4.3 Million - $5.76 Million
60,135 Added 12.73%
532,599 $47.8 Million
Q1 2018

May 07, 2018
SELL
$60.72 - $74.41 $4.99 Million - $6.12 Million
-82,188 Reduced 14.82%
472,464 $34.6 Million
Q4 2017

Jan 17, 2018
SELL
$44.96 - $58.99 $1.56 Million - $2.05 Million
-34,727 Reduced 5.89%
554,652 $32.2 Million
Q3 2017

Nov 13, 2017
BUY
$40.38 - $44.87 $23.8 Million - $26.4 Million
589,379
589,379 $26.4 Million

Others Institutions Holding HAE

# of Institutions
332
Shares Held
53.8M
Call Options Held
689K
Put Options Held
345K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.93B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email